Aug 1, 2024 08:00AM
Aug 8, 2022 04:17PM
Jul 27, 2022 04:05PM
Jul 27, 2022 06:59AM
Jun 3, 2022 09:10AM
Jun 3, 2022 06:59AM
Jun 3, 2022 06:59AM Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
May 10, 2022 04:05PM
May 10, 2022 08:33AM
May 10, 2022 08:30AM
Apr 28, 2022 07:31AM
Apr 28, 2022 07:30AM
Apr 28, 2022 07:30AM
Apr 28, 2022 07:30AM Turning Point Therapeutics and Zai Lab Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study
Apr 12, 2022 04:46PM
Apr 12, 2022 04:46PM
Mar 21, 2022 08:00AM
Feb 28, 2022 04:02PM
Jan 20, 2022 09:02AM
Jan 20, 2022 09:00AM
Jan 18, 2022 09:02AM Turning Point Therapeutics Inc. (TPTX) Outlines 2022 Clinical and Discovery Pipeline Milestones
Jan 18, 2022 09:00AM
Dec 20, 2021 08:03AM
Dec 20, 2021 08:00AM
Nov 9, 2021 04:01PM
Oct 13, 2021 04:01PM
Oct 8, 2021 08:31AM
Oct 8, 2021 08:30AM Turning Point Therapeutics Presents TRIDENT-1 Study Clinical Data for Repotrectinib in NTRK+ Advanced Solid Tumors in Plenary Session at 2021 AACR-NCI-EORTC Conference
Oct 7, 2021 07:00AM
Oct 4, 2021 09:10AM
Oct 4, 2021 09:02AM
Oct 4, 2021 09:00AM
Aug 11, 2021 04:35PM
Aug 11, 2021 04:01PM
Aug 9, 2021 04:02PM Turning Point Therapeutics Reports Second-Quarter Financial Results, Provides Operational Updates
Jun 17, 2021 08:30AM
May 5, 2021 04:05PM
Apr 13, 2021 05:44AM
Apr 12, 2021 09:00AM
Apr 12, 2021 09:00AM
Apr 5, 2021 04:02PM
Apr 5, 2021 04:01PM Turning Point Therapeutics Announces Initial Clinical Data From Phase 1/2 SWORD-1 Study of RET Inhibitor TPX-0046
Apr 5, 2021 04:01PM
Mar 1, 2021 04:02PM
Mar 1, 2021 04:02PM
Jan 29, 2021 08:32AM
Jan 29, 2021 08:30AM
Jan 29, 2021 08:30AM
Jan 11, 2021 07:42AM Turning Point Therapeutics (TPTX) Announces 2021 Milestone Targets
Jan 11, 2021 07:40AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All